Expert lecture
home > Expert lecture > list page
Expression of Folate Receptor Alpha and it's Clinical Significance in Breast Carcinoma 2016-01-11
Dr. Ping Tang is Professor of Pathology at University of Rochester Medical Center. Dr. Tang is a surgical pathologist with a subspecialty interest in breast pathology. Her educational background includes a research fellowship at Harvard Medical School, a PhD from MD Anderson Cancer Center in Houston Texas and a Fellowship in Surgical Pathology from Yale-New Haven Hospital in Connecticut. Dr. Tang’s impressive career has yielded extensive research publications and her current appointment at URMC.
Understanding the Importance of Molecular Classification as a Complementary Tool to IHC in Difficult 2016-01-11
Date: October 26th, 2013 Time: 9:00am EST (USA) Dr. Michael C. Dugan is the Chief Medical Officer at bioTheranostics, Inc. in San Diego, CA. He has served as assistant professor of pathology at both UCLA and Wayne State University School of Medicine. Dr. Dugan earned his bachelor’s degree in biology from the University of Notre Dame and his medical degree from the University of Arizona College of Medicine. He completed postgraduate training at Yale-New Haven Hospital, Children’s Hospital Los Angeles, and UCLA. “Understanding the Importance of Molecular Classification as a Complementary Tool to IHC in Difficult-to-Diagnose Metastatic Cancer”
Neuropathology: Neuronal, Embryonal and Meningeal Tumors 2016-01-11
Dr. Charlie Hao is currently Associate Professor of Pathology & Laboratory Medicine, Neuropathology at Emory University School of Medicine. He is very well published in the field of neuropathology and experimental pathology, with research emphasis in apoptotic pathways and therapeutic targets in cancers and cancer stem cells. Dr. Hao’s research aims to illustrate apoptotic pathways in glioblastoma, the most malignant brain tumor, for the development of cancer therapeutic agents targeting the apoptotic pathways. His research lab currently has two major projects underway; the objective of the first project is to molecularly dissect TRAIL-induced apoptotic pathway and its targeted cancer therapies, while the second project focuses to establish glioblastoma-derived cancer stem cells as cancer therapeutic targets. Date: October 20, 2012. Time: 9:00AM to 10:15AM EST (USA). Neuropathology: Neuronal, Embryonal and Meningeal Tumors Walk away with more insight on pathology. Walk away with more insight of pathology.
Molecular Diagnostics and Personalized Medicine of Colorectal Cancer 2016-01-11
Date: December 21st, 2013 Time: 9:00am EST (USA) “Molecular Diagnostics and Personalized Medicine of Colorectal Cancer”
CNS Demyelinating Disease Pathology, Especially Neuropathology 2016-01-11
our featured speaker today is Dr. Douglas C. Miller. Douglas C Miller is currently Clinical Professor in the Department of Pathology & Anatomical Sciences of the University of Missouri School of Medicine in Columbia, MO. Dr Miller is a native of New York City, did his undergraduate studies at Williams College and got his MD degree at the University of Miami School of Medicine in 1978. He stayed in Miami to complete his PhD work, earning that degree in the Department of Physiology & Biophysics in 1980. He did his residencies at the Massachusetts General Hospital and Harvard Medical School (Anatomic Pathology 1980-82; Neuropathology 1982-84). He is certified in Anatomic Pathology and Neuropathology by the American Board of Pathology. Dr Miller has been full-time faculty first at the UMDNJ-Robert Wood Johnson Medical School (Assistant Professor of Pathology, 1984-87), and then at New York University School of Medicine (Assistant Professor of Pathology and Neurosurgery, 1987-1994; Associate Professor of Neuropathology & Neurosurgery 1994-2002; Professor of Neuropathology & Neurosurgery, 2002-2007), before moving to Missouri and assuming his current appointment. Dr Miller has published extensively (over 140 papers and chapters) in several areas of neuropathology, mostly concerning primary brain tumors but also neurodegenerative diseases and infectious and inflammatory disorders. He has always taught and emphasized the importance of correlations between clinical data, neuroimaging data, and neuropathology: for example he was co-author on one of the earliest studies of MR imaging correlated with neuropathological findings, and he established that the pathological basis of the movement disorder in a large kindred with familial parkinsonism was actually Parkinson’s Disease, a finding which led to the discovery that Lewy Bodies were largely composed of alpha-synuclein.
Related Category
Promotion Products
  • Partners
  • Links
USCAP  |   CAP  |   IAP  |   TPIS  |   ASC  |   CAP-ACP  |   ASIP  |   AMP  |   ASCP  |   CAPA  |  
Home  |  News  |  Journals  |  Cases  |  Lectures  |  Experts  |  Telepath  |  Research  |  Conferences  |  Job_Position  |  Books  |  Sponsors
2009-2015 All Rights Reserved GoPath Diagnostics, LLC.